At least one normal ABL1 allele is usually present in cells expressing BCR-ABL1, acting as a tumor suppressor, as its knockout in CML CP cells leads to increased survival of cells in vitro and development of much more aggressive leukemia in mice [66]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.